Canndescent Pitch Deck (2019): 20-Slide Series C Deck

Canndescent's 2019 Series C deck is a sophisticated example of how to present a cannabis company as a high-end Consumer Packaged Goods (CPG) powerhouse. The deck successfully distances the brand from 'counterculture' tropes, instead leaning into CPG best practices, vertical integration, and rigorous market data. With a 700% CAGR through 2018 and a revenue run rate of $37.1M, the company demonstrates significant traction in the competitive California market. The presentation excels at showing how their 'effect-based' naming convention (Calm, Cruise, Create, Connect, Charge) simplifies the cons…

Key takeaways

• The company achieved a 700% revenue CAGR through 2018, reaching a $37.1M run rate (Slide 3).
• Canndescent commands a 2.4x market price premium compared to the average California spot price (Slide 12).
• The brand simplifies cannabis by replacing 6,000 confusing strain names with five desired outcomes: Calm, Cruise, Create, Connect, and Charge (Slide 7).
• Vertical integration is a core pillar, with 75,000 sq ft of cultivation and processing space and 14 California licenses (Slide 5).
• The deck highlights a 'Starbucks' consumer target, moving away from 'counterculture' branding toward aspirational messaging (Slide 7).
• Market validation is shown through scatter plots where Canndescent is the outlier, marrying high volume with the highest retail price per gram (Slide 11).
• The management team is presented as 'institutional quality,' featuring a CEO with five exits and executives from Mattel, P&G, and Snapple (Slide 18).
• Future growth is predicated on a 'house of brands' strategy, expanding into value, women-focused, and athletic segments (Slide 14).

Frequently asked questions

What is Canndescent's core value proposition?

Canndescent positions itself as a luxury CPG brand that simplifies the cannabis buying process. Instead of using traditional strain names like 'OG Kush,' which they claim confuse consumers, they categorize products by five desired effects: Calm, Cruise, Create, Connect, and Charge. This consumer-centric approach allows them to target the 'Starbucks' consumer and maintain a significant price premium over competitors.

How does the deck demonstrate market traction?

The deck uses three primary metrics: revenue growth, account penetration, and pricing power. Slide 12 shows a jump from 5 accounts in Q4 2016 to 398 in Q2 2019, alongside a revenue increase from $0.5M to $6.3M in the same period. Crucially, they use scatter plots on Slides 10 and 11 to show they are the only brand successfully combining high sales volume with a premium price point.

What is the company's operational strategy?

Canndescent follows a vertically integrated model. According to Slide 8, they manage everything from cultivation (67,000 sq ft) and processing to manufacturing (Cold CO2 extraction) and distribution (12 trucks, 500 deliveries per month). This control over the supply chain is presented as a way to ensure product consistency and 'pure and natural' quality standards.

Who is the target audience for this pitch deck?

This is a Series C deck intended for institutional investors. The language is professional and focuses on CPG terminology like 'CAGR,' 'SKUs,' 'Account Penetration,' and 'Strategic Beachhead.' The 'Who's Accountable' slide (Slide 18) emphasizes 'Institutional Quality' by highlighting executives with backgrounds at blue-chip companies like P&G, Citi, and ConAgra.

What are the primary growth drivers mentioned?

Growth is driven by three factors: product expansion, brand diversification, and geographic scaling. Slide 13 outlines a roadmap to move beyond flower into vapes, concentrates, ingestibles, and beauty products. Slide 14 illustrates a 'shelf' strategy where they plan to launch new brands (like 'goodbrands' and 'Volcannics') to capture 3x more shelf space across luxury, premium, and value segments.

Canndescent pitch deck: the facts

Company

Canndescent

Year

2019

Stage

Later (Series C)

Slides

20

Sector

Cannabis / CPG

Deck type

Investor Presentation

Outcome

Raised $27.5M

Headquarters

California, USA

Canndescent pitch deck PDF

The full Canndescent deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Canndescent pitch deck was used for

This deck is Canndescent’s **2019 Series C** pitch used to raise **$27.5 million in Series C Preferred Funding** for its luxury cannabis / CPG business. The company, operating as Fiore Management, LLC (d/b/a Canndescent), presents itself as California’s leading luxury flower brand, emphasizing “effects” rather than strains and targeting the “Starbucks” consumer underserved by existing cannabis offerings. The capital was earmarked to expand into new product categories (vapes and ingestibles) and to support regional expansion into markets such as Massachusetts, Nevada, Canada and other geographies. The deck positions California as a strategic “beachhead” platform from which the brand can extend nationally via new products, brands, geographies, and channels, while highlighting rapid historical growth and price premium metrics from its existing operations.

Business model: Canndescent is a California-based cannabis cultivator and branded goods company that positions itself as a **luxury cannabis / CPG** brand, focusing on premium flower and expanding into vapes and ingestibles. It operates as a vertically integrated producer, managing cultivation, processing, manufacturing, and distribution (“seed-to-retail”).

Year

2019

Raised

$27.5 million.

Lead investor

Green Acre Capital.

Investors

Green Acre Capital (lead)., Carnegie Arch Capital., Senterra LLC., Altitude Investment Management., JW Asset Management., A multinational beer company from Asia (undisclosed by name)., Supporting financial advisors: DelMorgan & Company and Benchmark (advisory roles, not equity investors).

Headquarters

Santa Barbara, California, United States.

Industry

Cannabis; Consumer Packaged Goods (CPG).

Round: Series C Preferred funding (described as Series C, sometimes classified as Series C - II in databases).

Total funding: Canndescent has raised multiple rounds including a $6.5M seed round in 2016, a $10M Series B in 2018, a $13M Series C convertible in 2018, and a $27.5M Series C preferred round in September 2019.

Use of funds as presented: Expansion into vapes and ingestibles and support for regional expansion into markets including Massachusetts, Nevada, Canada and other geographies.

What happened after the Canndescent deck

The 2019 Series C deck successfully supported Canndescent’s closing of a $27.5M Series C preferred round at an estimated $200–$300M valuation. The company deployed the capital to expand product categories and enter new markets, building on prior seed, Series B, and Series C convertible financings, while navigating operational and market challenges typical of the cannabis sector.

• Canndescent closed **$27.5 million in Series C Preferred Funding** in September 2019, led by Green Acre Capital with par
• Business Insider reported that this Series C round valued the company between **$200 million and $300 million**, accordi
• Prior to the 2019 Series C deck, Canndescent had raised a **$6.5M seed round** in 2016, a **$10M Series B** in early 201
• Press coverage indicates that Canndescent used the Series C funds to drive expansion into **vapes and ingestibles** and
• Separate reporting notes that Canndescent laid off 16 people shortly before closing the Series C, suggesting operational

What the Canndescent deck got right

• Compelling leadership and growth narrative in the California luxury segment. The deck positions Canndescent as **California’s #1-selling luxury flower brand** with a reported **700% CAGR** and a substantial **price premium** (150%–2.4x over market averages), which offers investors a clear story of category leadership and strong historical growth in a highly competitive market.
• Distinct consumer-centric, effects-based branding strategy. Canndescent’s **effects-based brand architecture** (focusing on outcomes like Calm, Cruise, Create rather than strain names and cannabinoid jargon) directly addresses mainstream consumer pain points such as confusion, inconsistent experiences, and counterculture stigma, enabling a differentiated and consumer-friendly positioning.
• Demonstrated vertical integration and operational scale. The company presents itself as a **vertically integrated CPG operator**, controlling seed-to-retail across cultivation, processing, manufacturing, and distribution, with tens of thousands of square feet in operation and additional capacity coming online in 2019. This conveys operational depth beyond a single-brand marketing play.
• Clear articulation of California as a scalable platform for national expansion. The deck and external coverage highlight **California as a strategic beachhead**, emphasizing its size, margins, and trend-setting role, and arguing that securing California premium flower creates a platform to expand across the U.S. via new products, brands, geographies and channels—an attractive scaling thesis for investors.
• Specific, growth-oriented use of funds tied to product and geographic expansion. The fundraising narrative is supported by concrete **capital deployment plans**, including expansion into vapes and ingestibles and geographic growth into Massachusetts, Nevada and Canada, which shows investors specific growth levers that the Series C capital will fund.
• Inclusion of formal forward-looking disclosures appropriate for a regulated sector. In a highly regulated sector, the inclusion of a detailed **forward-looking statements and risk disclosure** slide signals some level of governance and legal rigor in communications, which is often appreciated by institutional investors evaluating cannabis deals.

What could have been stronger

• Leadership and growth claims lack clearly presented supporting data in the deck excerpts. The deck references Canndescent as “California’s #1-selling luxury flower” and cites 700% CAGR with a 150%–2.4x price premium, but there is limited explicit third-party data in the deck itself to substantiate these rankings and growth figures (e.g., specific BDS Analytics charts, share data, or methodology are not clearly presented in the OCR excerpts). This can make it harder for investors to independently validate the claimed leadership and growth from the deck alone.
• Limited detail on regulatory and licensing execution in new markets. While the deck stresses California as the strategic beachhead and mentions expansion into other states and countries, it provides limited visible detail on regulatory strategy, licensing status, or operational readiness in those new markets, which are critical risk factors in cannabis. Absent more explicit coverage of regulatory and licensing milestones, investors may see a gap between ambition and documented execution outside California.
• Customer and unit economics not clearly quantified in visible slides. The OCR text highlights strong qualitative framing of consumer pain points (confusion, inconsistent experiences, counterculture branding) and an effects-based solution, but there is little visible quantification of customer economics—such as cohort retention, repeat purchase rates, or unit economics—within the slides provided, which are often important for later-stage investors.
• Risk discussion appears relatively light in the marketing narrative. The disclosure slide makes clear the presence of forward-looking statements and risks, but the deck excerpts do not show a detailed risk section or downside scenarios (e.g., pricing compression, regulatory delays, capital intensity of expansion). For a capital-intensive, highly regulated category, this can be perceived as underweight risk discussion in the marketing narrative.
• Operational efficiency metrics are not prominently documented in the excerpted slides. Although the company describes itself as a vertically integrated operator with significant square footage of cultivation and processing, the OCR does not show a clear breakdown of capacity utilization, yield per square foot, or cost-per-gram benchmarks compared with peers. For a later-stage Series C, investors may expect more operational benchmarks to complement the brand story.

How an investor would read this deck

What draws attention

• Verification of the claim that Canndescent is **California’s #1-selling luxury flower brand**, including third-party retail sell-through data, BDS Analytics share metrics, or comparable market research.
• Detailed breakdown of the reported **700% CAGR** and **150%–2.4x price premium**—time period, base revenue, and how premium pricing has held up across different retailers and regions.
• Understanding the strength and defensibility of the **effects-based brand architecture** (Calm, Cruise, Create, etc.), including consumer research demonstrating that mainstream users prefer this simplification over strain-based or technical cannabinoid labeling.
• Evaluating the scalability of the vertically integrated model from California to other states and countries, including the capital requirements and regulatory hurdles for replicating cultivation and branded distribution.
• Reviewing the company’s financial trajectory across seed, Series B, and both Series C rounds to assess revenue growth, margin trends, cash burn and path to profitability given the capital-intensive nature of cannabis cultivation.

Risks that stand out

• Regulatory and licensing risk in new markets (Massachusetts, Nevada, Canada and other states), where changes in cannabis policy, licensing delays or local opposition could slow or prevent planned expansion fueled by the Series C capital.
• Market saturation and price compression risk in California’s highly competitive cannabis market, which could erode Canndescent’s ability to maintain its reported price premium and luxury positioning.
• Execution risk around scaling a vertically integrated, premium-focused operation; rapid expansion in cultivation and new product lines may stretch management capacity and could lead to quality inconsistency that undermines the brand promise.
• Financing and capital structure risk, given the sequence of multiple rounds (seed, Series B, Series C convertible, Series C preferred) in a sector where access to capital can fluctuate and later rounds or debt may introduce dilution or restrictive terms.
• Operational risk related to labor and cost controls, highlighted by reporting that Canndescent laid off staff around the time of the Series C raise, raising questions about cost structure and responsiveness to market conditions.

Questions this deck invites

• What independent market data (e.g., BDS Analytics, Headset) confirms Canndescent’s position as California’s leading luxury flower brand, and how is “luxury” defined in those datasets?
• How has Canndescent’s **price premium** (150%–2.4x over market average) affected volume growth, customer retention and retailer relationships over time? Is there evidence of price compression in later periods?
• What licenses and regulatory approvals has Canndescent secured in Massachusetts, Nevada, Canada and other target markets, and what is the timeline and capital budget for fully activating those markets?
• How do Canndescent’s cultivation and processing metrics (yield per square foot, cost per gram, product rejection rates) compare with leading California and multi-state operators, and how are these metrics expected to change as new square fo
• What were the key performance milestones or covenants attached to the $27.5M Series C preferred round, and how has the company performed relative to those milestones since closing the round?

What founders can take from the Canndescent deck

• A clear, differentiated **brand thesis**—in this case, repositioning cannabis from strain jargon to an effects-based, lifestyle-oriented luxury brand—can be a powerful narrative anchor in later-stage fundraising, especially when tied to specific target consumers like the “Starbucks” consumer.
• Positioning a core market (California) as a **strategic beachhead** with compelling macro characteristics (largest market, high margins, global trend-setter) helps investors see how success in one region can translate into a scalable national platform.
• Combining strong **traction metrics** (e.g., high CAGR, price premium, market leadership) with clear storytelling around consumer pain points (confusion, inconsistency, counterculture image) creates a cohesive case for why a brand deserves growth capital.
• Explicit **forward-looking disclosures** acknowledging risks and uncertainties, as seen in the deck’s disclosure slide, are important in regulated, volatile sectors like cannabis, and help align expectations around forward-looking statements.
• Detailing **use of funds**—here, expansion into vapes and ingestibles and entry into new geographies—shows investors a concrete capital deployment plan linked directly to growth levers, rather than a generic call for working capital.
• For cannabis and other regulated industries, demonstrating **vertical integration** (seed-to-retail) with specific operational scale metrics (square footage of cultivation, processing, manufacturing and distribution) can strengthen credibility as an emerging platform rather than a single-product bra

Canndescent pitch deck: common questions

How much did Canndescent raise with the 2019 Series C pitch deck?

Canndescent used this 2019 pitch deck to raise **$27.5 million in Series C Preferred Funding**. The round was described as a Series C - II by some data providers, but contemporaneous press releases and media coverage refer to it simply as a Series C preferred round.

Who invested in Canndescent’s 2019 Series C round?

The 2019 Series C round was **led by Green Acre Capital**, a cannabis-focused venture fund from Canada. Other named investors in the round include **Carnegie Arch Capital, Senterra LLC, Altitude Investment Management, JW Asset Management**, and a **multinational beer company from Asia** whose name was not disclosed.

What valuation did Canndescent receive in its 2019 Series C fundraising?

According to Business Insider’s coverage of the Series C, CEO Adrian Sedlin stated that the **$27.5M round valued Canndescent at between $200 million and $300 million**. This valuation range is specific to the 2019 Series C preferred raise and reflects investor expectations at that time, not current valuation.

What was the use of funds for Canndescent’s 2019 Series C round?

Canndescent used the Series C capital to **expand into vapes and ingestibles** and to support **regional expansion** into **Massachusetts, Nevada, Canada and other markets**. The deck itself also frames California as a strategic beachhead to launch additional products, brands, geographies, and channels over time, consistent with this expansion strategy.

What are the main positioning and traction claims in Canndescent’s Series C deck?

The deck and accompanying coverage describe Canndescent as **California’s #1-selling luxury flower brand**, growing at a **700% compound annual growth rate (CAGR)** and maintaining roughly a **150%–2.4x price premium** over market averages. It emphasizes a consumer-friendly “effects-based” product architecture (e.g., Calm, Cruise, Create) instead of technical strain names, aiming to serve the mainstream “Starbucks” consumer seeking consistency, quality, and simplified choices.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

• Canndescent $27.5 Million Series C Pitch Deck: California Cannabis
• Canndescent Closes $27.5 Million Series C Preferred Funding
• California marijuana company Canndescent closes $13 million funding round
• Canndescent: Funding, Team & Investors | Startup Intros
• CULTIVATED: Canndescent lands new funding, social justice activists versus corporate cannabis, and more.
• Canndescent - Company Profile - Tracxn
• Canndescent Deal Terms
• Canndescent Laid Off 16 People Before Closing $27.5 Million...

Canndescent pitch deck slides

What each slide of the Canndescent pitch deck says

Slide 3

A VERTICALLY INTEGRATED CANNABIS BRAND CATEGORY DETAILS ~ i Industry Commercial Cannabis CN Markets United Stales (CA, NV, MA); Canada | EieS Company Status Private & CA Licenses Held 14; cultivation, nursery, processing, | ) ANNOESCENT manutactaring, distribution, non- | storefront retail and events Business Mods! Premium CPG | ——— Brands Canndescent, goodbrands - Products Flower, Pre-rolls, Concentrates, Ingestibes | CEO Adrian Sediin | - Distribution Footprint >50% penetration in CA + One of the industry’s most recognized er ———————————————————— and highly regarded cannabis brands Revanue CAGR 700% through 2018 | + California's #1-selling, flower brand? 2018 Revenue 104M | + Pioneer of a…

Slide 4

DISCLOSURE This summary contains forward-looking statements and information relating to Fiore Management, LLC (d/b/a Canndescent) {the "Company" or "Canndescent") that are based on the beliefs and assumptions made by the company's management. When used in this document, the words "anticipate", "believe", "estimate", and "expect" and similar expressions, are intended to identify forward-looking statements. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary…

Slide 5

KEY INVESTMENT HIGHLIGHTS Cannabis is the fastest growing industry on the planet — Countries and states are legalizing at an accelerating rate, while consumers are rapidly adopting cannabis for health, wellness and relaxation The leading luxury cannabis brand - California's #1-selling luxury flower', growing at a 700% CAGR while maintaining a 150% premium?in the most competitive cannabis market in the world A Vertically Integrated CPG Company - Canndescent operates its brands from seed-to-retail, including 75K sq ft (6,970 m) of cultivation, processing, manufacturing and distribution with another 53K sq ft (4,925 m) set for delivery in 2019 Diversified Revenue Streams — Multiple revenue str…

Slide 6

Source: "MJ B HOW YOU WIN THE CANNABIS RACE CANNDESCENT'S STRATEGIC BEACHHEAD CALIFORNIA #1 cannabis market Highest margin * Industry platform 5th largest economy' Underserved $7.7B by 2022 Highest growth Genetics are IP 50 year head start Not winner-take-all * Not a commo Breeds jungle lions Easy to expand 5 Drives global trends Anchors brand house THE COMPANY THAT SECURES CALIFORNIA PREMIUM FLOWER CAN LEVERAGE THE PLATFORM TO DOMINATE THE U.S. CANNABIS INDUSTRY, LAUNCHING NEW PRODUCTS, BRANDS, GEOGRAPHIES AND DISTRIBUTION CHANNELS OVER TIME atan; *BDS Analytics CREATE

Slide 7

WHERE WE STARTED CONSUMER PAIN POINTS Today's market materially underserves the "Starbucks" consumer WHAT THE MARKET DELIVERS WHAT CONSUMERS WANT MEDIOCRE PRODUCTS. Prohibition scared off talent and capital, creating a cottage industry of subpar offerings INCONSISTENT EXPERIENCES. Providers using very different genetics and techniques market products under the same name CONFUSION AND INTIMIDATION. Market overwhelms consumers with 6,000 strain names and overly technical information about cannabinoids, terpenes, CBD, CBN, CBG, THCa, THCyv, and flavonoids. .. COUNTERCULTURE PARADOX. Incredible health and wellness product marketed as the misogynistic offspring of Cypress Hill x Duck Dynasty OPA…

Slide text above is read directly from the Canndescent deck PDF embedded on this page.

Related fundraising guides (24)

• How to Create a Pitch Deck Competition Slide Investors Actually Like
• Pitch Deck Design: A Founder's Guide to Balancing Text and Visuals
• Pitch Decks That Raise Millions: A Tactical Guide
• How to End Your Pitch: A Guide to the Final Slides, Q&A, and Closing
• Less Text, More Investment: A Tactical Guide To Pitch Decks That Raise Capital
• Tesla Pitch Deck Breakdown
• Monzo Pitch Deck Breakdown: Building the Bank of the Future
• The 11 Investor Questions You Must Nail After Your Pitch
• SWOT Analysis for Fundraising: A Founder's Guide to Pitching Investors
• How to Write an Executive Summary That Gets Investors to Reply
• The Team Slide: A Founder's Guide to Acing Your Seed Round Pitch
• How to Design a Pitch Deck That Makes a Strong First Impression
• The Founder's Guide to SMART Goals That Actually Get You Funded
• The Right Charts for Your Pitch Deck and How to Use Them
• How To Share Your Pitch Deck Without an NDA
• How to Know if Your Pitch Deck Is Actually Good
• The Real Cost of a Pitch Deck
• The Structure of a Pitch Deck: A Founder's Slide-by-Slide Guide
• Pendo Series B Pitch Deck Breakdown
• How to Pitch a Hardware Startup and Get Funded
• How to Present Your Pitch Deck to Investors
• How to Show Your Competitor Landscape in a Pitch Deck
• Forget the 50-Page Business Plan: These 3 Documents Get You Funded
• How to Prepare an Investor Pitch That Actually Closes

This deck's categories (5)

• Consumer & Social Pitch Deck Examples
• Ecommerce & Retail Pitch Deck Examples
• Hardware, Deeptech & Climate Pitch Deck Examples
• Logistics, Mobility & Supply Chain Pitch Deck Examples
• Food, Beverage & Hospitality Pitch Deck Examples

Decks from the same year (1)

• 2019 pitch deck examples

Decks from the same region (1)

• US pitch deck examples

Decks with a similar raise (1)

• Pitch decks that raised $10M to $50M

Browse companies alphabetically (1)

• Pitch decks from companies starting with C

Decks in the same category (12)

• Agile Wash Pitch Deck Breakdown: Four Real Slides In A 37-Page Template
• Super.com Pitch Deck Breakdown: The $60M Series C Deck, Slide by Slide
• Exeq Pitch Deck Breakdown: The 2017 Consumer Fintech Deck That Left Its Business Model in Another File
• Tinder (Match Box) Pitch Deck Breakdown
• Squareboat Pitch Deck Breakdown: What a Company Deck Gets Right (and Why It Would Fail With Investors)
• AKO Smart Technologies Pitch Deck Breakdown: Real Trial Data, and a Budget That Contradicts It
• VCCEdge Pitch Deck Breakdown: Fourteen Slides of Data, Zero Analysis
• Voro Pitch Deck Breakdown: Leveraging Real Identity in Healthcare Social Networking
• Cafetino Pitch Deck Breakdown: All 12 Slides Analysed (2020 Deck)
• Evntr Pitch Deck Breakdown: All 13 Slides Analysed (2015 Deck)
• KangaDo Pitch Deck Breakdown: A Trust Business With No Trust Slide
• Stockmeister Pitch Deck Breakdown: Nine Confident Slides With Nothing Underneath

More pitch deck teardowns (16)

• Indifi Pitch Deck Teardown: A Late-Stage Fintech Playbook for MSME Lending in India
• Canela Media Pitch Deck Breakdown: Dominating the Hispanic AVOD Market
• Canexxia Pitch Deck Teardown: A Roll-Up Strategy for the Senior Home Healthcare Market
• Can-Fite BioPharma Pitch Deck Teardown: A Clinical-Stage Asset Play in Multi-Billion Dollar Markets
• Canix Pitch Deck Breakdown: Scaling Cannabis ERP with High Capital Efficiency
• Canlan Ice Sports Pitch Deck Teardown: A 2010 Look at Multi-Revenue Recreational Facilities
• Cannabis Energy Oil Pitch Deck Teardown: A Minimalist Look at Biofuel Speculation
• Cannassure Pitch Deck Teardown: A Public Market Play for Vertically Integrated Cannabis
• CanniMed Therapeutics Pitch Deck Teardown: A Post-IPO Pharmaceutical Pivot Strategy
• CanniMed Pitch Deck Teardown: Scaling Pharmaceutical-Grade Cannabis for Global Markets
• Cann Pitch Deck Teardown: Positioning Cannabis as a Mainstream Alcohol Alternative
• Cansativa Pitch Deck Breakdown: Betting on the German Cannabis Monopoly
• CanSport LIVE Pitch Deck Teardown: A B2B Sales Deck for Amateur Sports Digitalization
• Cantina Fácil Pitch Deck Teardown: A B2B2C Play for School Nutrition Management
• Canva Pitch Deck Breakdown: Disrupting a $138.4B Market with Design Democratization
• Capacity Pitch Deck Breakdown: A Masterclass in High-Level Narrative Over Granular Metrics

Recently published pitch deck teardowns (12)

• Peoplewave Pitch Deck Teardown: A High-Efficiency Seed Ask for HR Tech
• PerfectDashboard Pitch Deck Teardown: Converting Web Projects into Recurring Revenue
• PersonalCare Pitch Deck Teardown: Targeting the 1% with Concierge Medicine Management
• Pickle Pitch Deck Teardown: Gamifying the Selfie Trend with Viral Social Mechanics
• Pharmadigit Pitch Deck Teardown: Digitizing the $7B Algerian Pharmaceutical Market
• Phanatiq Pitch Deck Teardown: A Gamified Fan Engagement Play for the Music Industry
• Pictofy Pitch Deck Teardown: A Hardware-Enabled Marketplace for Event Photography
• Phybbit Pitch Deck Teardown: Quantifying the ¥2.6 Billion Ad Fraud Opportunity
• PingTank Pitch Deck Teardown: A Case Study in Platform-Dependent Social Expression
• Pixc Pitch Deck Teardown: A Masterclass in Demo Day Brevity and Visual Proof
• Startup Pirates Pitch Deck Teardown: A Community-Driven Accelerator Expansion Model
• PipelineVR Pitch Deck Teardown: A B2B Marketplace Play in the 2017 VR Hype Cycle

Browse by topic (1)

• Pitch Deck guides

Fundraising library · Pitch deck examples · Investor directory · Founder database